🔎 Trials Near Me

Gara Jalqabaatti › Dhukkuba Kroonii › Florida › Miami

Qorannoo klinikaalii Dhukkuba Kroonii Miami, FL keessatti

Qorannoo 19 Dhukkuba Kroonii f Miami fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Namoota walitti qabaa jiraSadarkaa 3
  • Sanchez Clinical Research ( Site 5144), Miami
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Namoota walitti qabaa jiraSadarkaa 2
  • Research Associates of South Florida /ID# 280929, Miami
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Namoota walitti qabaa jiraSadarkaa 4
  • Gastro Health Research - Miami, Miami
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • A Plus Research /ID# 265878, Miami
  • Sanchez Clinical Research /ID# 265887, Miami
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06548542

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Sanchez Clinical Research, Inc, Miami
  • Biodax Medical Research Trials, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 2/3
  • Sanchez Clinical Research, Inc, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Namoota walitti qabaa jiraSadarkaa 3
  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937099

Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease

Namoota walitti qabaa jira
  • University of Miami, Miami
Umuriin 16 hanga 75 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07671872

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Columbus Clinical Services LLc-Site Number: 8400038, Miami
  • Regis Clinical Research, LLC-Site Number: 8400041, Miami
  • Sylvester Comprehensive Cancer Center - A University of Miami Hospital and Clinics Facility - Miami-Site Number: 8400111, Miami
  • fi 4 dabalataa
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Columbus Clinical Services LLc-Site Number: 8400038, Miami
  • Bioresearch Partner-Kendale Lakes-Site Number: 8400053, Miami
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07184944

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Bioresearch Partner-Kendale Lakes, Miami
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Gastro Health Research - Miami, Miami
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07483073

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Gastro Health Research - Miami, Miami
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07483099

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Sanchez Clinical Research, Inc, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07577843

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07237516

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Research Associates of South Florida, LLC, Miami
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Elb-2026 · NCT06456593

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

Namoota walitti qabaa jiraSadarkaa 4
  • University of Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Bit-2026 · NCT06774079

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Investigational Site Number 8400028, Miami
  • Investigational Site Number: 8400012, Miami
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Mirador Therapeutics Selected Site, Miami
  • Mirador Therapeutics Selected Site, Miami
  • Mirador Therapeutics Selected Site, Miami
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 12-Bit-2026 · NCT07113522

Qorannoo Dhukkuba Kroonii magaalota biroo keessatti

Qorannoo biroo Miami keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.